Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Change in Account Payables (2023 - 2025)

CervoMed (CRVO) has disclosed Change in Account Payables for 8 consecutive years, with $94899.0 as the latest value for Q4 2025.

  • Quarterly Change in Account Payables fell 77.88% to $94899.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$67322.0 through Dec 2025, down 107.93% year-over-year, with the annual reading at -$67322.0 for FY2025, 107.93% down from the prior year.
  • Change in Account Payables hit $94899.0 in Q4 2025 for CervoMed, up from -$434813.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $429005.0 in Q4 2024 to a low of -$434813.0 in Q3 2025.
  • Historically, Change in Account Payables has averaged $112234.7 across 3 years, with a median of $211375.5 in 2023.
  • Biggest five-year swings in Change in Account Payables: surged 453.47% in 2024 and later crashed 221.94% in 2025.
  • Year by year, Change in Account Payables stood at $182494.0 in 2023, then soared by 135.08% to $429005.0 in 2024, then plummeted by 77.88% to $94899.0 in 2025.
  • Business Quant data shows Change in Account Payables for CRVO at $94899.0 in Q4 2025, -$434813.0 in Q3 2025, and -$76566.0 in Q2 2025.